Postbiotics Market worth $224.8 million by 2030- Exclusive Report by MarketsandMarkets™
The demand for postbiotics is projected to rise significantly, driven by growing consumer interest in microbiome health and the inherent limitations of probiotics and prebiotics in terms of viability and stability. Postbiotics, composed of non-living microbial cells and metabolites, offer proven health benefits without the need for live microorganisms. Their high stability under extreme processing conditions makes them ideal for a wide range of product formulations, including shelf-stable dietary supplements, functional foods, and beverages. Heat-treated bacterial strains, most notably Lactobacillus and Bifidobacterium, are widely recognized for their safety and scientifically supported benefits in gut, immune, and skin health. As consumer demand for microbiome-friendly solutions continues to grow, postbiotics are well-positioned to capture a larger share of the biotics market.
Browse in-depth TOC on "postbiotics Market"
250– Tables30– Figures200– Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237110254
Postbiotics in dry form to account for the fastest growth during the forecast period
Postbiotic powders are versatile forms and attractive to consumers; they are expected to be the most rapidly growing during the forecast period because postbiotic powders offer a highly concentrated dose of bioactive compounds that can be easily incorporated into multiple food and drink formats such as smoothies, cereals, and snack bars-a boon for modern lifestyles with taste and convenience intact. From a manufacturing perspective, their dry, heat-stable nature makes it easy to process them without major modifications to existing equipment or product systems. In addition, the increasing disillusionment of consumers with conventional pills has made powders, gummies, and bars alternative delivery formats all the more popular. Although live probiotics may fail in such formats, postbiotics overcome this hurdle, much more so in dry form, making them the best solution for the manufacturers as well as health-conscious consumers. This combination of formulation ease, shelf stability, and growing end-user preference underlines why dry form postbiotics are expected to witness the steepest growth in future years.
Cosmetics and personal care products segment to hold greater market share during the forecast period
The trend of skinimalism increasingly embraces everything simple and multifunctional in skincare, thereby rapidly increasing the demand for postbiotics. Postbiotics address numerous benefits within a singular formulation. They have been introduced into cosmetics such as moisturizing creams intended to restore the hydrolipid barrier, anti-aging serums, and hair care containing agents that strengthen the scalp and improve hair condition. Coupling their multifunctionality with safety and stability makes postbiotics suitable for sensitive, acne-prone, or otherwise problematic skin. They do not pose the risk of microbial overgrowth as live probiotics do, making them ideal for products aimed at restoring the skin's natural microbiome balance. With increasing eco-awareness and health-consciousness among consumers, and as interest rises in Clean Beauty and microbiome-friendly skincare, especially into 2025, postbiotics are expected to establish themselves as the active ingredient of choice within modern beauty. The anti-inflammatory, antioxidant, and barrier-supporting qualities of postbiotics thus enhance their efficacy and safety and have driven the postbiotic to ever-rising prominence in next-generation cosmetics and personal care products.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=237110254
European region to hold a significant market share in the global postbiotics market
Most of the European consumers now claim to use dietary supplements, which reveals the growing trend toward preventive health and wellness. Growing consumer engagement creates a conducive environment for the postbiotic markets as people turn to scientifically validated, gut-friendly sources for postbiotics that can be easily incorporated into daily routines through supplements and functional foods. Active participation of the major regional players with respect to Associated British Foods plc (UK), can also be the reason of European postbiotic growth. In November 2023, AB Biotek Human Nutrition & Health (UK), subsidiary of ABF (UK) sealed a partnership deal with Tetra Pak (Switzerland) to come up with innovative postbiotic solutions for food & beverage, making it easy to incorporate postbiotics into mainstream products such as dairy, plant-based drinks, and snacks without any special equipment for their manufacturing. Such partnerships widen the simplicity of the formulation of products and visibility and accessibility of postbiotic-enriched offerings. With this innovation, seen by one of the dominant European players, ABF (UK), bringing postbiotics closer to consumers through the most consumed formats, public awareness is anticipated to grow quickly, and the market is expected to expand across the region.
The report profiles key players such as Cargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), dsm-firmenich (Netherlands), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), and Bioprox Healthcare (France).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=237110254
Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting
Related Reports:
Functional Food Ingredients Market by Type (Probiotics, Protein & Amino Acids, Phytochemicals & Plant Extracts, Prebiotics, Omega-3 Fatty Acids, Carotenoids, Vitamins), Application, Source, Form, Health Benefits and Region - Global Forecast to 2029
Probiotics Market Size, Share, Analysis, & Growth Trends Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets Inc.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comResearch Insight: https://www.marketsandmarkets.com/ResearchInsight/postbiotics-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/postbiotics.asp
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/postbiotics-market-worth-224-8-million-by-2030-exclusive-report-by-marketsandmarkets-302515946.html
SOURCE MarketsandMarkets
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
How To Put $100 In Your Retirement Fund Each Month With Sun Communities Stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Sun Communities Inc. (NYSE:SUI) is a real estate investment trust that owns, operates, and develops manufactured housing and recreational vehicle communities, as well as marinas. It will report its Q3 2025 earnings on Nov. 3. Wall Street analysts expect the company to post EPS of $2.14, down from $2.34 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $709.45 million, down from $939.90 million a year earlier. The 52-week range of Sun Communities' stock price was $109.22 to $147.83. Sun Communities' dividend yield is 3.28%. It paid $4.16 per share in dividends during the last 12 months. Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— The Latest On Sun Communities The company on July 30 announced its Q2 2025 earnings, posting FFO of $1.76, compared to the consensus estimate of $1.68, and revenues of $623.50 million, compared to the consensus of $602.15 million, as reported by Benzinga. 'We are pleased to report strong second quarter results with earnings ahead of our expectations, as we demonstrated the strength of our platform. It was also one of the most pivotal quarters in our history as we completed the previously announced sale of Safe Harbor Marinas and repositioned Sun as a pure-play owner and operator of manufactured housing and RV communities with a best-in-class balance sheet. This transaction streamlined operations, unlocked meaningful financial flexibility, and enhanced shareholder value,' said CEO Gary A. Shiffman. The company updated its 2025 guidance, now expecting core FFO per share in the range of $6.51 to $6.67. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. How Can You Earn $100 Per Month As A Sun Communities Investor? If you want to make $100 per month — $1,200 annually — from Sun Communities dividends, your investment value needs to be approximately $36,585, which is around 288 shares at $126.83 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (3.28% in this case). So, $1,200 / 0.0328 = $36,585 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis. For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Sun Communities stock an attractive option for making a steady income of $100 per month by owning 288 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Sun Communities has raised its dividend consecutively for the last nine years. Read Next: $100k+ in investable assets? – no cost, no obligation. Image: Shutterstock This article How To Put $100 In Your Retirement Fund Each Month With Sun Communities Stock originally appeared on Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
Yahoo
6 minutes ago
- Yahoo
Ready to Enroll in Medicare? Here's Why You May Want to Wait on Social Security.
Key Points Age 65 is when Medicare eligibility typically begins. Though you can sign up for Social Security at that point, waiting could result in larger benefits. Do not be confused into thinking you have to sign up for both programs at the same time. The $23,760 Social Security bonus most retirees completely overlook › Many Americans get health insurance through their employers. So when they retire, they're forced to find another solution. And for a lot of older Americans, that solution is Medicare. Medicare eligibility typically begins at 65. You can actually enroll a few months ahead of your 65th birthday to ensure that you have coverage in place at that point. You may be aware that if you're old enough to get Medicare, it means you're also old enough to sign up for Social Security. But here's why you may want to wait on Social Security if you're signing up for Medicare at 65. You don't want to slash your monthly benefits Many people end up kicking off retirement with limited savings. If that's you, you may end up pretty reliant on Social Security to cover your expenses. And even if you have decent savings, your money could run out. So it's important to try to get as much Social Security as you can. To that end, you may not want to claim Social Security at 65 if you're signing up for Medicare at that point. If you were born in 1960 or later, your full retirement age for Social Security purposes is 67. Claiming benefits ahead of full retirement age will reduce them permanently, leaving you with less retirement income for life. The earliest you can file for Social Security is at age 62. In that case, you're looking at about a 30% reduction in your monthly checks compared to waiting until full retirement age. If you file for Social Security at 65 in conjunction with your Medicare enrollment, you're looking at a smaller reduction -- about 13.34%. But remember, that's a reduction you'll face every single month you collect Social Security. So you may be better off enrolling in Medicare at 65 but waiting at least a bit longer before filing for Social Security. You don't need Social Security to get Medicare One big misconception about Medicare is that you have to be enrolled in Social Security to get that health coverage. If you're getting Social Security, you'll have your monthly premiums for Medicare Part B paid directly out of your benefits. But that doesn't mean you must be on Social Security to get Medicare. If you're not collecting monthly benefits, all it means is that you'll have to pay your Medicare premiums another way. And you can set up automatic payments so you don't have to think about them. You may even want to claim Social Security past full retirement age Not only might 65 be premature to claim Social Security, but you should also know that delaying your filing beyond full retirement age could result in a huge reward. For each year you hold off on Social Security past that point, up until age 70, your benefits get an 8% boost. That boost is a permanent one. And the extra money could do you a world of good once you're no longer actively earning an income. All told, it's important to understand how Medicare and Social Security work together before signing up for either. But you should know that being on Social Security is not a requirement for Medicare enrollment. And if you're signing up for Medicare at 65, waiting on Social Security could mean setting yourself up for less financial stress throughout your retirement. The $23,760 Social Security bonus most retirees completely overlook If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known could help ensure a boost in your retirement income. One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these Motley Fool has a disclosure policy. Ready to Enroll in Medicare? Here's Why You May Want to Wait on Social Security. was originally published by The Motley Fool Sign in to access your portfolio
Forbes
8 minutes ago
- Forbes
CDC: Childhood Vaccination Rates Fell Further In 2024-2025 School Year
Childhood vaccination rates dropped even further for the 2024-2025 school year down to the lower 92% range with a record number of exemptions from vaccinations among kindergarteners, according to new data from the U.S. Centers for Disease Control and Prevention. Meanwhile, this year the U.S. has already experiencing the most measles cases and outbreaks that it's had in years with 1,333 and 29, respectively. Gee, do you think these things are somehow connected in any way? Well, the likely answer rhymes with the word 'mess.' Childhood Vaccination Rates Have Fallen To The 92% Range 'A mess' can describe what used to be a tidy public health situation. The newest CDC data shows that measles, mumps, rubella vaccination coverage among kindergarteners continued a downward trend. Rates have dropped from 95.2% in the 2019-2020 school year down to 92.7% in the 2023-2024 school year and even further to 92.5% this past school year. Coverage numbers for other vaccines have been going the wrong direction as well. Rates for the diphtheria, tetanus, and acellular pertussis vaccine otherwise known as the DTaP vaccine have fallen from 94.9% in 2019-2020 to 92.3% in 2023-2024 to 92.1% this past school year. Over the same time periods. the percentage of kids who got two doses of the varicella vaccine went from 94.8% to 92.3% to 92.1%. And coverage for the polio vaccine has gone from 95% to 92.7% to 92.5%. All of this has corresponded to a rise in the number of parents seeking exemptions from vaccinations for their children, going from 2.5% in the 2020-2021 schools year to 3.3% in 2023-24 to 3.6% in 2024-25. The U.S. basically had an all-time record number of such exemptions last school year with around 138,000 children getting them for at least one vaccine. And this isn't an issue in just a few states painted a certain political color. The majority of states (36 of them) in the U.S. as well as the District of Columbia had increases in exemptions from the previous. In fact, 17 states saw exemption rates that went above 5%. And which state do you think had the highest rate of exemptions? It rhymes with 'I don't know.' Idaho had the highest rate at a whopping 15.4% 2025 Has Already Had 1,333 Confirmed Measles Cases, 29 Outbreaks Meanwhile, the U.S. continues to go back in time when it comes to the measles. Measles outbreaks were very common before the arrival of the measles vaccine in the 1960s. Then over time as vaccination coverage increased, the threat of measles decreased. Once measles vaccination rates stayed above the herd immunity threshold of 95% for years, measles became rarer and rarer. That was because with such a large percentage of the population vaccinated, the measles virus had trouble finding unprotected humans to infect and treat like a cheap motel to reproduce and spread further. Eventually, the measles virus was effectively gone baby gone from the U.S., which declared measles eliminated in 2000. How quickly people forget, though. Since 2000, persistent misinformation and disinformation about the measles vaccine have helped erode MMR vaccination rates. Over the past decade, I've been writing more and more about measles cases and outbreaks, like this one, in the U.S. mainly because more and more measles cases and outbreaks have been occurring. I've written about I wrote in Forbes in 2019 about how anti-vaxxers made that year's World Health Organization's list of top ten global health threats All of this brings us to this year, which has been a great year if you are the measles virus. Not so great for many humans. As of July 29, there's already been a total of 1,333 confirmed measles cases across 40 jurisdictions, according to CDC data. Try to find the states that are not among the following that have had reported measles cases: Alaska, Arkansas, Arizona, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York City, New York State, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington and Wyoming. Oh, and measles is really contagious. Like really, really contagious. Among unvaccinated people, one case can easily lead to 12 to 18 more cases. About 87% of all reported measles cases this year have been part of outbreaks. This year has also already had 29 reported outbreaks, up from 16 in all of 2024. Lack Of More Urgent Action Dropping vaccination rates and rising measles cases and outbreaks should be more than a canary in a coal mine for the U.S. It should be a freaking elephant. We've essentially allowed a problem that was taken care of to return and potentially make America measle-ly again. Not only that. With other vaccination rates declining as well, we could see resurgences of other infectious disease as well, including polio. Things could be reversed if prompt actions are taken to get vaccination rates back up again before the different nasty microbes can spread too far in the U.S. population. But there doesn't seem to be an organized effort at the federal level to address these worsening problems. In fact, there are disturbing trends in the opposite direction such as the layoffs of personnel who were dedicated to help control infectious diseases, claims being made about vaccines that are unsupported by scientific evidence and cuts in funding for scientific research and public health efforts. The CDC website still has language about vaccination being simply a personal choice. But that simply is not the case. Since the percentage of people vaccinated affects the spread of viruses and other microbes, each person's decision to get vaccinated affects everyone else's risk of getting the disease. Therefore, having people around you not vaccinated against say the measles raises your risk of your risk of getting the measles, even if you yourself are already vaccinated against the measles. In other words, childhood vaccinations are not simply child's play.
